SS 19 - Bio 3: Genomics and Biomarkers

Moderator(s)

• 

  Yun Li, MD, PhD

  City of Hope National Medical Center
  Duarte, CA
• 

  Scott Bratman, MD, PhD

  Princess Margaret Hospital
  Toronto, ON, Canada

Presentations:

• 10:45 AM – 10:55 AM ET

  Assessment of Circulating Tumor Cells in Oligometastatic Castration-Sensitive Prostate Cancer Patients from the ORIOLE Trial
  

  Presenter: Soha Bazyar, MD, PhD – University of Maryland
• 10:55 AM – 11:05 AM ET

  Does Detection of Tumor-Associated Mutations in Proximal Lymph Predict Relapse in HPV-Negative Head and Neck Cancer Patients?
  

  Presenter: Aadel Chaudhuri, MD, PhD – Mayo Clinic Alix School of Medicine
• 11:05 AM – 11:15 AM ET

  Associations Between Genetic Alterations in Follicular Lymphoma and Radiosensitivity
  

  Presenter: N. Ari Wijetunga, MD, PhD, MS – University of North Carolina
• 11:15 AM – 11:25 AM ET

  Prognostic Implications of Cerebrospinal Fluid Circulating Tumor DNA (CSF ctDNA) Following Radiation Therapy in Patients with Leptomeningeal Metastasis: Analysis of a Randomized Phase II Trial
  

  Presenter: Alexander Goglia, MD, PhD – Memorial Sloan Kettering Cancer Center
• 11:25 AM – 11:35 AM ET

  Characterizing Radiation Induced Subclonal Kinetics in Pancreatic Ductal Adenocarcinoma
  

  Presenter: Vincent Bernard Pagan, MD, PhD – MD Anderson Cancer Center
• 11:35 AM – 11:45 AM ET

  Circulating Tumor Cell-Based Molecular Biomarkers of ¹⁷⁷Lu-PSMA-617 Treatment Efficacy in Metastatic Prostate Cancer
  

  Presenter: David Miyamoto, MD, PhD – Massachusetts General Hospital
• 11:45 AM – 11:55 AM ET

  Discussant
  

  Discussant: Kent Mouw, MD, PhD – Dana-Farber/Brigham and Women's Cancer Center